P04 Category · further specificity required Newborn affected by noxious substances transmitted via placenta or breast milk
ICD-10-CM P04 identifies “Newborn affected by noxious substances transmitted via placenta or breast milk” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 16: Certain conditions originating in the perinatal period
Code-level instructions
Includes1
nonteratogenic effects of substances transmitted via placenta
Excludes 24
- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Code first1
any current condition in newborn, if applicable
Inherited instructions
Chapters 16 · Certain conditions originating in the perinatal period (P00-P96)
Includes1
conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
Excludes 25
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- tetanus neonatorum (A33)
Note1
Codes from this chapter are for use on newborn records only, never on maternal records
P00-P04 · Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04)
Note1
These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
More specific codes
P04.0Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and deliveryBillable / specificP04.1Newborn affected by other maternal medicationCategory · further specificity requiredP04.2Newborn affected by maternal use of tobaccoBillable / specificP04.3Newborn affected by maternal use of alcoholBillable / specificP04.4Newborn affected by maternal use of drugs of addictionCategory · further specificity requiredP04.5Newborn affected by maternal use of nutritional chemical substancesBillable / specificP04.6Newborn affected by maternal exposure to environmental chemical substancesBillable / specificP04.8Newborn affected by other maternal noxious substancesCategory · further specificity requiredP04.9Newborn affected by maternal noxious substance, unspecifiedBillable / specificOfficial index references
References from other codes (13)
Excludes 2 · newborn affected by noxious substances transmitted via placenta or breast milk (P04.-)
Excludes 2 · nonteratogenic effects of substances transmitted via placenta or breast milk (P04.-)
Excludes 2 · newborn affected by noxious substances transmitted via placenta or breast milk (P04.-)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
History
Code history
Latest recorded change · FY2022
Effective from
- Code-level rules changed
Newborn affected by noxious substances transmitted via placenta or breast milk
Category — select a more specific code
CDC/NCHS · FY2022All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Title changed · Code-level rules changed · Inherited rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | Code-level rules changed |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.